AnaptysBio outperformed the market index on August 7, 2025, while the company was noted to be in a specific industry sector.
2 reports, 1 independent
Updated Jul 29
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AnaptysBio outperformed the market index on August 7, 2025, while the company was noted to be in a specific industry sector.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- ZacksAnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates AnaptysBio, Inc. (ANAB) came out with a quarterly loss of $1.34 per share versus the Zacks Consensus Estimate of a loss of $1.5. This c